BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33475023)

  • 21. Inhibition of sphingosine kinase 2 attenuates hypertrophic scar formation via upregulation of Smad7 in human hypertrophic scar fibroblasts.
    Zeng J; Jiang B; Xiao X; Zhang R
    Mol Med Rep; 2020 Sep; 22(3):2573-2582. PubMed ID: 32705254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of microRNA-296 in rabbit hypertrophic scars and its role to human fibroblasts].
    Guo BY; Lin F; Bai ZM; Tao K; Wang HY
    Zhonghua Shao Shang Za Zhi; 2021 Aug; 37(8):725-730. PubMed ID: 34404160
    [No Abstract]   [Full Text] [Related]  

  • 23. Mast cell chymase in keloid induces profibrotic response via transforming growth factor-β1/Smad activation in keloid fibroblasts.
    Dong X; Zhang C; Ma S; Wen H
    Int J Clin Exp Pathol; 2014; 7(7):3596-607. PubMed ID: 25120737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-21 promotes collagen production in keloid via Smad7.
    Zhou R; Wang C; Wen C; Wang D
    Burns; 2017 May; 43(3):555-561. PubMed ID: 27717618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Expression of DNMT1 in Pathologic Scar Fibroblasts and the Effect of 5-aza-2-Deoxycytidine on Cytokines of Pathologic Scar Fibroblasts.
    E Y; Qipa Z; Hengshu Z
    Wounds; 2014 May; 26(5):139-46. PubMed ID: 25860431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High temperature requirement factor A1 (HTRA1) regulates the activation of latent TGF-β1 in keloid fibroblasts.
    Jin SF; Wang YX; Xu N; Sun Q; Wang CC; Lv MZ; Sun X; Guo S
    Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):107-110. PubMed ID: 29412803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
    Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
    J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars.
    Zhang ZF; Zhang YG; Hu DH; Shi JH; Liu JQ; Zhao ZT; Wang HT; Bai XZ; Cai WX; Zhu HY; Tang CW
    Burns; 2011 Jun; 37(4):665-72. PubMed ID: 21236582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TSG-6 Inhibits the Growth of Keloid Fibroblasts Via Mediating the TGF-β1/Smad Signaling Pathway.
    Li XY; Weng XJ; Li XJ; Tian XY
    J Invest Surg; 2021 Sep; 34(9):947-956. PubMed ID: 31986937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
    Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC
    Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.
    Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y
    J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased epidermal thickness and abnormal epidermal differentiation in keloid scars.
    Limandjaja GC; van den Broek LJ; Waaijman T; van Veen HA; Everts V; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
    Br J Dermatol; 2017 Jan; 176(1):116-126. PubMed ID: 27377288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of the Transforming Growth Factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell Migration are Mediated by Ubiquitin Specific Protease 4 (USP4) in Hypertrophic Scar Tissue and Primary Fibroblast Cultures.
    Huang Y; Wang Y; Wang X; Lin L; Wang P; Sun J; Jiang L
    Med Sci Monit; 2020 Apr; 26():e920736. PubMed ID: 32308208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological and immunochemical differences between keloid and hypertrophic scar.
    Ehrlich HP; Desmoulière A; Diegelmann RF; Cohen IK; Compton CC; Garner WL; Kapanci Y; Gabbiani G
    Am J Pathol; 1994 Jul; 145(1):105-13. PubMed ID: 8030742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
    He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
    Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts.
    Kopp J; Preis E; Said H; Hafemann B; Wickert L; Gressner AM; Pallua N; Dooley S
    J Biol Chem; 2005 Jun; 280(22):21570-6. PubMed ID: 15788410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The distrubution of cell cycle on fibrolasts derived from the pathlogical scars and analysis of Fas gene mutations in keloids using polymerse chain Reaction-based single-strand conformation polymorphism].
    Lu F; Gao j ; Li X
    Zhonghua Yi Xue Za Zhi; 2000 Sep; 80(9):709-12. PubMed ID: 11798842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes of Smad2 and type I collagen expressions on cultured human Tenon's capsule fibroblasts transfected with Smad7 vector].
    Chen JY; Sun XH
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Jun; 39(3):265-70. PubMed ID: 16944602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Periostin is induced by IL-4/IL-13 in dermal fibroblasts and promotes RhoA/ROCK pathway-mediated TGF-β1 secretion in abnormal scar formation.
    Maeda D; Kubo T; Kiya K; Kawai K; Matsuzaki S; Kobayashi D; Fujiwara T; Katayama T; Hosokawa K
    J Plast Surg Hand Surg; 2019 Oct; 53(5):288-294. PubMed ID: 31066603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.